These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 33514642

  • 1. Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy.
    Canney M, Barbour SJ, Zheng Y, Coppo R, Zhang H, Liu ZH, Matsuzaki K, Suzuki Y, Katafuchi R, Reich HN, Cattran D, International IgA Nephropathy Network, International IgA Nephropathy Network Investigators.
    J Am Soc Nephrol; 2021 Feb; 32(2):436-447. PubMed ID: 33514642
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy.
    Thompson A, Carroll K, A Inker L, Floege J, Perkovic V, Boyer-Suavet S, W Major R, I Schimpf J, Barratt J, Cattran DC, S Gillespie B, Kausz A, W Mercer A, Reich HN, H Rovin B, West M, Nachman PH.
    Clin J Am Soc Nephrol; 2019 Mar 07; 14(3):469-481. PubMed ID: 30635299
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressive agents for treating IgA nephropathy.
    Natale P, Palmer SC, Ruospo M, Saglimbene VM, Craig JC, Vecchio M, Samuels JA, Molony DA, Schena FP, Strippoli GF.
    Cochrane Database Syst Rev; 2020 Mar 12; 3(3):CD003965. PubMed ID: 32162319
    [Abstract] [Full Text] [Related]

  • 6. Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study.
    Tang C, Chen P, Si FL, Lv JC, Shi SF, Zhou XJ, Liu LJ, Zhang H.
    Am J Kidney Dis; 2024 Aug 12; 84(2):170-178.e1. PubMed ID: 38364955
    [Abstract] [Full Text] [Related]

  • 7. Remission of proteinuria improves prognosis in IgA nephropathy.
    Reich HN, Troyanov S, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry.
    J Am Soc Nephrol; 2007 Dec 12; 18(12):3177-83. PubMed ID: 17978307
    [Abstract] [Full Text] [Related]

  • 8. Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria.
    Komatsu H, Sato Y, Miyamoto T, Tamura M, Nakata T, Tomo T, Nishino T, Miyazaki M, Fujimoto S.
    Clin Exp Nephrol; 2016 Feb 12; 20(1):94-102. PubMed ID: 26123429
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
    Chen D, Liu J, Duan S, Chen P, Tang L, Zhang L, Feng Z, Cai G, Wu J, Chen X.
    Kidney Blood Press Res; 2018 Feb 12; 43(2):318-328. PubMed ID: 29529608
    [Abstract] [Full Text] [Related]

  • 10. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
    Yu GZ, Guo L, Dong JF, Shi SF, Liu LJ, Wang JW, Sui GL, Zhou XJ, Xing Y, Li HX, Lv JC, Zhang H.
    Am J Kidney Dis; 2020 Jul 12; 76(1):90-99. PubMed ID: 32197881
    [Abstract] [Full Text] [Related]

  • 11. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy.
    Hoshino Y, Moriyama T, Uchida K, Tsuchiya K, Nitta K.
    Clin Exp Nephrol; 2017 Aug 12; 21(4):617-623. PubMed ID: 27549901
    [Abstract] [Full Text] [Related]

  • 12. Immunosuppressive therapy in patients with IgA nephropathy.
    Peters HP, van den Brand JA, Berger SP, Wetzels JF.
    Neth J Med; 2015 Jul 12; 73(6):284-9. PubMed ID: 26228193
    [Abstract] [Full Text] [Related]

  • 13. Long-Term Outcomes in IgA Nephropathy.
    Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, Steenkamp R, Wong K, Turner AN, Wang K, Gale DP, Barratt J.
    Clin J Am Soc Nephrol; 2023 Jun 01; 18(6):727-738. PubMed ID: 37055195
    [Abstract] [Full Text] [Related]

  • 14. The Association of Low Hemoglobin Levels with IgA Nephropathy Progression: A Two-Center Cohort Study of 1,828 Cases.
    Zhu B, Liu WH, Yu DR, Lin Y, Li Q, Tong ML, Li YY, Yang RC, Du YY, Tang XL, Jiang F, Fei D, Wei XY, Zhang FF, Yin JZ, Wang WR, Li XF, Sun Y, Zhong YZ, Zhang MJ, Cheng XX, Zhu CF, Chen HY.
    Am J Nephrol; 2020 Jun 01; 51(8):624-634. PubMed ID: 32694247
    [Abstract] [Full Text] [Related]

  • 15. Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study.
    Rehnberg J, Symreng A, Ludvigsson JF, Emilsson L.
    J Am Soc Nephrol; 2021 Feb 01; 32(2):411-423. PubMed ID: 33177116
    [Abstract] [Full Text] [Related]

  • 16. Utility of remission criteria for the renal prognosis of IgA nephropathy.
    Matsuzaki K, Suzuki H, Kawamura T, Tomino Y, Suzuki Y.
    Clin Exp Nephrol; 2021 Sep 01; 25(9):988-995. PubMed ID: 33974158
    [Abstract] [Full Text] [Related]

  • 17. Estimated glomerular filtration rate and daily amount of urinary protein predict the clinical remission rate of tonsillectomy plus steroid pulse therapy for IgA nephropathy.
    Suzuki K, Miura N, Imai H.
    Clin Exp Nephrol; 2014 Aug 01; 18(4):606-12. PubMed ID: 24052158
    [Abstract] [Full Text] [Related]

  • 18. Optimal proteinuria target for renoprotection in patients with IgA nephropathy.
    Nam KH, Kie JH, Lee MJ, Chang TI, Kang EW, Kim DW, Lim BJ, Park JT, Kwon YE, Kim YL, Park KS, An SY, Oh HJ, Yoo TH, Kang SW, Choi KH, Jeong HJ, Han DS, Han SH.
    PLoS One; 2014 Aug 01; 9(7):e101935. PubMed ID: 25003873
    [Abstract] [Full Text] [Related]

  • 19. Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children.
    Zhao JL, Wang JJ, Huang GP, Feng CY.
    Medicine (Baltimore); 2021 May 28; 100(21):e26050. PubMed ID: 34032732
    [Abstract] [Full Text] [Related]

  • 20. Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.
    Maeda I, Hayashi T, Sato KK, Shibata MO, Hamada M, Kishida M, Kitabayashi C, Morikawa T, Okada N, Okumura M, Konishi M, Konishi Y, Endo G, Imanishi M.
    Nephrol Dial Transplant; 2012 Jul 28; 27(7):2806-13. PubMed ID: 22492824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.